Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for COO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
April 30, 2026 -7.20%
January 31, 2026 12.77%
October 31, 2025 7.94%
July 31, 2025 9.27%
April 30, 2025 8.75%
January 31, 2025 10.81%
October 31, 2024 11.54%
July 31, 2024 10.44%
April 30, 2024 9.43%
January 31, 2024 8.72%
October 31, 2023 9.11%
July 31, 2023 9.17%
April 30, 2023 4.54%
January 31, 2023 9.85%
October 31, 2022 7.73%
July 31, 2022 11.67%
April 30, 2022 15.26%
January 31, 2022 12.11%
October 31, 2021 14.53%
July 31, 2021 80.67%
April 30, 2021 16.33%
January 31, 2021
October 31, 2020 11.91%
July 31, 2020 9.55%
April 30, 2020 2.19%
Date Value
January 31, 2020 14.00%
October 31, 2019 17.50%
July 31, 2019 17.68%
April 30, 2019 18.71%
January 31, 2019 16.43%
October 31, 2018 15.44%
July 31, 2018 15.27%
April 30, 2018 9.65%
January 31, 2018 -20.76%
October 31, 2017 15.78%
July 31, 2017 18.63%
April 30, 2017 19.67%
January 31, 2017 15.19%
October 31, 2016 11.66%
July 31, 2016 17.14%
April 30, 2016 15.39%
January 31, 2016 11.51%
October 31, 2015 8.13%
July 31, 2015 9.80%
April 30, 2015 14.06%
January 31, 2015 13.87%
October 31, 2014 6.68%
July 31, 2014 20.50%
April 30, 2014 19.31%
January 31, 2014 17.84%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 19.20%
West Pharmaceutical Services, Inc. 17.65%
Abbott Laboratories 7.37%
Stryker Corp. 19.37%
Solventum Corp. 4.16%